Fennec Pharmaceuticals Inc (NASDAQ:FENC), a biopharmaceutical company focused on the development of PEDMARK for the prevention of platinum-induced ototoxicity in pediatric cancer patients, has reported a significant insider sell transaction.
Related Keywords
, Fennec Pharmaceuticals Inc , Pharmaceuticals , Rosty Raykov ,
comparemela.com © 2020. All Rights Reserved.